Home Blog Page 2211

Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025

BOSTON, Oct. 14, 2025 /PRNewswire/ — Complete Genomics, a leading innovator in genomic sequencing, today announced a series of milestones at the American Society of Human Genetics (ASHG) Annual Meeting, Oct. 14–18, 2025 in Boston.

At ASHG 2025, for the first time, Complete Genomics will host a DNBSEQ™ User Group Meeting to bring together researchers and customers to share best practices, explore applications across oncology, rare disease and population genomics, and hear updates from the company on product innovations. The meeting will take place on Tuesday, Oct. 14, 2025, 8:30 a.m. – 5:00 p.m. EDT in the Marina Ballroom of the Westin Boston Seaport District. The session will feature customer presentations and networking opportunities designed to foster collaboration among the growing DNBSEQ user community. For more information, visit completegenomics.com/boston-user-group-meeting-2025.

For a full listing of Complete Genomics programming at ASHG, visit completegenomics.com/events/ashg-2025, including:

  • CoLab Presentation (Oct. 15, 10:15 a.m., Theater 2, Exhibit Hall): Corbin Jones (UNC Chapel Hill) will share early insights into spatial gene expression in microscopic colitis using Stereo-seq.
  • Industry Workshop (Oct. 16, 3:00 p.m., Room 204AB): Stanford’s Michael Snyder and Johns Hopkins’ Sam Curtis will present on longitudinal iPOP multi-omics and AI-informed approaches to multi-cancer detection.
  • Poster Sessions: Researchers from Stanford and Bio-Rad will present on the unbiased spatial profiling of the intestine, integrated single-cell RNA-seq with Bio-Rad ddSEQ and DNBSEQ-T1+RS*, and longitudinal multi-omics profiling with DNBSEQ technologies.

Earlier this year at the Advances in Genome Biology and Technology (AGBT) conference, Complete Genomics unveiled the DNBSEQ-T1+RS sequencer, designed for cost-effective and scalable sequencing across a wide range of applications. The system has now begun shipping in the U.S. market. Through the early access program for the DNBSEQ-T1+RS, data was generated across a wide range of applications with partners ranging from single cell RNA-seq, whole exome sequencing, PGT-A, and oncology. Ongoing partnerships include testing compatibility with methylation and proteomics samples. Selected datasets will be available on the completegenomics.com/learn/demo-data. 

The STOmics product line also continues to expand with the addition of two new offerings: the new Large Chip Designs v1.3 (starting from 1cm x 2 cm and beyond), enabling larger-scale spatial transcriptomics studies, and the enhanced DNBSEQ-T7RS Stereo-seq Visualization Reagent Set (T7 STO FCL PE75) sequencing kits, delivering improved performance and flexibility for researchers.

“With the launch of the DNBSEQ-T1+RS in the U.S., the expansion of our STOmics portfolio, and several key partnerships, 2025 has been a pivotal year for Complete Genomics,” said Rob Tarbox, VP of Product and Marketing. “We’re strengthening collaborations, expanding U.S. manufacturing, and bringing researchers together at our first DNBSEQ User Group Meeting to advance the next generation of genomic discovery.”

Complete Genomics continues to partner with top U.S. research institutions.

Mayo Clinic in Arizona is set to become a Complete Genomics Certified Service Provider for STOmics Stereo‑seq spatial transcriptomics technology. This collaboration is expected to expand Mayo Clinic’s capabilities in advanced spatial biology, enabling large-scale, high-resolution transcriptomic analysis to support a broad range of translational research applications. 

Researchers at the Salk Institute for Biological Studies, including Dr. Elsa Molina, Director of the Salk Single-Cell & Spatial Omics Core, and Dr. Yuan Sui, NOMIS–Salk Fellow in the Professor Tony Hunter Lab, are currently conducting a pilot study with Complete Genomics’ San Jose R&D team to evaluate STOmics spatial transcriptomics technology. The study aims to generate unbiased, spatially resolved whole-transcriptome data for comparison with other spatial platforms in use at Salk. Results from this collaboration are expected to be shared in the near future. 

Complete Genomics has also partnered with Bio-Rad to advance single-cell and spatial transcriptomics by combining Bio-Rad’s ddSEQ™ Single-Cell Isolator and SEQuoia™ RiboDepletion Kit with the high-throughput DNBSEQ-T7RS sequencer. Together, these solutions deliver proven performance on single-cell libraries and enable advanced spatial sequencing with up to 50% lower sequencing costs and improved transcriptome data quality, offering researchers streamlined workflows and powerful new capabilities for discovery.

In addition, the company is expanding its U.S. reagent manufacturing facility in San Jose, California, beginning with reagents for the DNBSEQ-T7RS high-throughput sequencer with additional kits becoming available in the future. Local production will improve delivery times on selected products, making the Complete Genomics supply chain more resilient for U.S. customers. The expansion reinforces the company’s commitment to quality and compliance, ensuring production of consistent and dependable reagents to support our customers.

In support of local manufacturing, Complete Genomics has successfully completed Stage 1 and Stage 2 audits by TÜV and has been recommended for ISO 13485:2026 certification, with the final certificate expected within 60 days. This internationally recognized quality standard underscores the company’s commitment to rigorous product design, development, and quality management practices. The certification provides added assurance of product reliability and consistency—an increasingly important factor as DNBSEQ platforms gain adoption in translational and clinical research environments.

About Complete Genomics

Complete Genomics is a pioneering life sciences company that provides novel, complete sequencing solutions including sample/library preparation, lab automation, sequencing, and data analysis. The sequencing portfolio offers a full lineup of sequencers ranging from low, medium, and high throughput capacities, all powered by its proprietary DNBSEQ technology. More than 10,900 publications are based on DNBSEQ technology across a wide array of applications. To learn more, visit www.completegenomics.com.

* For Research Use Only. Not for use in diagnostic procedures.

Pictor’s Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle

New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA’s enhanced analytical performance through multiplexing and its potential to enhance global disease management. 

CARLSBAD, Calif., Oct. 14, 2025 /PRNewswire/ — Mycoplasma bovis is a devastating pathogen that threatens cattle health and productivity worldwide. In the United States alone, economic losses due to M. bovis mastitis are estimated to be above $100 million annually. While Mycoplasma bovis is not a human infection risk, it is a public health systems risk — through antimicrobial resistance, food security, and resource diversion.  Pictor Holdings Inc., a global leader in targeted, multiplex proteomics, announced the publication of a study detailing the development and performance of its novel Pictor PictVet™ Mycoplasma bovis Assay. This innovative assay offers a promising advancement in the early and accurate detection of Mycoplasma bovis infections, a critical step for global disease management and the health of cattle herds.

The research, conducted with funding from New Zealand’s Ministry for Primary Industries and the University of Melbourne, demonstrates excellent analytical performance and a high level of agreement with existing methods. The PictVet™ assay achieved a Positive Percent Agreement (PPA) of 100%, a Negative Percent Agreement (NPA) of 98.4%, and an overall agreement of 98.9% compared to the IDvet ELISA. This performance is supported by a unique multiplex design that uses two distinct Mycoplasma bovis antigens to enhance sensitivity and specificity.

“By incorporating multiple antigens, the PictVet™ assay achieves a level of sensitivity and specificity that sets a new benchmark for veterinary testing,” said Dr Yoichi Furuya, Chief Science Officer at Pictor. “This advancement ensures earlier and more reliable detection of Mycoplasma bovis infections, which is critical for effective disease management.”

The PictVet™ assay also demonstrated a superior limit of detection (LOD) compared to existing methods, which may enhance its ability to detect infections at lower antibody concentrations. Further studies are underway to evaluate its performance in diverse field conditions and validate its potential for early detection of Mycoplasma bovis infections.
Mycoplasma bovis continues to exact a heavy toll on the global cattle industry — from production losses and animal welfare impacts to the downstream effects on food security and antimicrobial resistance,” said Dr Paul Dick, President, Paul Dick & Associates Ltd. “Accurate, reliable, and affordable testing is essential. Without it, we’re managing blind — and that delays every decision farmers and veterinarians need to protect herd health and safeguard the food system.”

The PictVet™ assay was specifically designed to address gaps in current surveillance tools, offering a more reliable solution for managing Mycoplasma bovis outbreaks. The ability to detect infections early and accurately is critical for supporting eradication efforts, such as New Zealand’s ambitious campaign, and for safeguarding herd health on a global scale.

“This assay is not just a laboratory tool—it’s a solution that empowers farmers and veterinarians to take proactive steps in managing herd health,” said Dr Jamie Platt, CEO of Pictor. “At Pictor, we are committed to delivering innovations that make a real difference in both human and animal health, advancing the One Health approach.”

About Pictor
Pictor is a leader in flexible, targeted proteomics, delivering next generation multiplex solutions that empower clinical labs, diagnostic manufacturers, and veterinary providers worldwide. Powered by its patented PictArray™, PictImager™, and AI-powered Pictorial™ software, Pictor’s platform delivers deeper insights from a single sample, offering faster, more affordable, and scalable results.

From infectious diseases to oncology, Pictor’s innovative technology is advancing testing capabilities to support better human and animal health.  Headquartered in Carlsbad, California Pictor Holdings Inc. is committed to driving innovation through solutions designed for unmatched performance, cost efficiency and productivity.

Discover how Pictor is shaping the future of proteomics testing at www.pictordx.com.

Media Contact:
Kelly Krueger
415-235-5031
Kelly.krueger@audacityhealth.com

NYSE Content Advisory: Pre-Market Update + Etsy transfers stock listing to NYSE

NEW YORK, Oct. 14, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-Market Update + Etsy transfers stock listing to NYSE

Kristen Scholer delivers the pre-market update on October 14th

  • Equities are lower Tuesday morning after the S&P 500 booked its best daily rally since May, finishing Monday’s session up 1.6%. Volatility has returned to the markets since Friday amid concerns of escalation between the U.S. and China.
  • Today, Etsy is transferring its stock listing to the NYSE. The nearly $7 billion global online marketplace, led by CEO Josh Silverman, will ring the opening bell to celebrate.
  • Big Bank earnings begin in earnest today. Many of the largest firms, including NYSE-listed JPMorgan Chase, Wells Fargo, Goldman Sachs, and Citigroup all reported results this morning.

Opening Bell
Etsy (NYSE: ETSY) celebrates its transfer to the NYSE.

Closing Bell
Embraer (NYSE: ERJ) marks its 2025 Investor Day

Click here to download the NYSE TV App

 

bunq Accelerates Global Expansion with Premium Rewards Proposition Powered by Ascenda

Neobank elevates customer value and deepens engagement through Ascenda’s global rewards network

NEW YORK, Oct. 14, 2025 /PRNewswire/ — Ascenda, the loyalty company that powers growth for the world’s leading financial institutions, today announced its new partnership with bunq, Europe’s second-largest neobank. The collaboration elevates bunq’s loyalty program, unlocking superior rewards that power its users’ international lifestyle.

bunq’s skyrocketing trajectory – marked by its recent 20 million user milestone and plans for US expansion – is underpinned by a relentless user focus. As “the first bank people love to use,” bunq’s success is built on making life easy by using tech to remove the hassle of money admin. The new partnership with Ascenda is marked by a shared vision for superior user experiences and technology-driven innovation.

Enabled by Ascenda’s unrivaled loyalty ecosystem, bunq users across Germany, France, Spain, Ireland, and the Netherlands can now use their points to access a new range of aspirational rewards, such as airline miles. The collaboration showcases how innovative financial institutions are embedding premium, high-value rewards directly into their core products. The expanded loyalty proposition strengthens bunq’s appeal to new and existing customers, fueling customer acquisition and increasing stickiness.

“We’re excited to bring one of our most-requested features to users: earning airline miles, just by using their bunq card. At bunq, we’re all about making life easy. Our partnership with Ascenda helps us do exactly that: helping our users earn travel rewards from everyday spending to support their borderless lifestyle,” said Tom Bilske, Head of New Products.

“Loyalty is no longer a simple add-on to financial products – it’s a core engine for revenue and growth,” said Josh Berwitz, Chief Commercial Officer of Ascenda. “This new partnership demonstrates how a disruptive leader can leverage differentiated customer value to win in the market. bunq is making everyday banking truly rewarding and we’re thrilled to power their success.”

About bunq

Founded in 2012 by serial entrepreneur Ali Niknam, bunq has brought lasting change to the European banking industry. By having its users at the heart of the business and building a product rooted in their wants and needs, bunq quickly scaled to become the second-largest neobank in the EU. Serving those with an international lifestyle across the European Economic Area, bunq makes life easy for location-independent people and businesses, starting from the way they manage money: how they spend, save, budget, and invest.

Pioneering many things considered impossible, bunq was the first bank to get a European banking permit in over 35 years, raised the largest series A round ever secured by a European fintech (€193 million), and was the first EU neobank to achieve structural profitability at the end of 2022. On its mission to build the first global neobank for digital nomads, in April 2025, bunq announced it’s fast-tracking its entry in the US by applying for a broker-dealer license and planning to reapply for the full banking license later the same year.

About Ascenda 

Ascenda powers many of the world’s most iconic financial services products, enabling high-value, personalized rewards experiences that drive profitable behavior. With over a decade of proven results, an unrivaled roster of top-tier global clients, and enterprise-grade technology, Ascenda is trusted by leading brands to deliver growth outcomes, eliminate complexity, and create extraordinary customer experiences. For more information, please visit ascenda.com

Starburst Announces Winners of the 2025 Data Visionary Awards

Awards honor customers and partners who are redefining what’s possible with data and AI

BOSTON, Oct. 14, 2025 /PRNewswire/ — Starburst, the data platform for apps and AI, recognized the winners of the 2025 Data Visionary Awards at a celebration event held alongside AI & Datanova 2025 Thursday evening. The awards honor customers and partners who are harnessing data and AI to deliver transformative results, accelerate innovation, and shape the future of their industries.

The awards celebrate achievements across six customer categories and four partner categories, recognizing visionaries whose leadership and execution are pushing the boundaries of what’s possible with Starburst.

Customer Award Winners

  • AI & Data Visionary Award: S&P Global Market Intelligence – Enterprise Solutions Technology Team
    The Enterprise Solutions Technology team at S&P Global Market Intelligence is recognized for its bold vision and execution in building a modern, AI-ready data foundation leveraging Starburst. By embracing a federated, governed architecture, the team has accelerated innovation, reduced time-to-market, and set a new standard for responsible AI adoption.
  • Executive AI & Data Visionary Award Winner: Anna Nicanorova, CTO, Annalect
    Anna is recognized for her leadership in driving Annalect’s enterprise-wide data vision and AI transformation. By championing Starburst, she has accelerated insights, strengthened decision-making, and delivered measurable business impact across Annalect’s global operations.
  • Data AI Award Winner: Asurion
    Asurion is recognized for building a modern, AI-ready data foundation with Starburst, including Iceberg lakehouses, federated access, and strong governance. This approach positions Asurion for scalable AI adoption, future RAG use cases, and accelerated enterprise insights.
  • Impact Through AI Award Winner: Arity
    Arity is recognized for harnessing Starburst to power data-driven insights that improve transportation safety and efficiency. By applying AI to vast mobility datasets, Arity helps businesses and communities reduce risk, optimize operations, and make faster, more informed decisions, thereby delivering measurable impact across the transportation ecosystem.
  • Data Pathfinder Award Winner: Periyasamy Sivakumar (Siva), Head of Data Engineering, OCBC
    Siva is recognized for his leadership in driving Starburst adoption and data modernization at OCBC. Through hands-on influence and advocacy, he has delivered results in a complex, regulated environment and inspired peers across the organization.
  • Data Disruptor Award Winner: PSEG Long Island
    PSEG Long Island is recognized for its bold, fast-moving approach to transforming data and analytics. By leveraging Starburst to modernize access to critical data and accelerate insights, PSEG Long Island demonstrated how a forward-thinking organization can disrupt traditional practices and drive meaningful impact.

Partner Award Winners

  • Starburst Partner: Data Visionary Award Winner: Amazon Web Services, Inc. (AWS)
    AWS is recognized for advancing cloud-native AI and data solutions that empower enterprises to unlock transformative insights and accelerate business value with Starburst.
  • Starburst Partner: Data Trailblazer Award Winner: Dell Technologies
    Dell is celebrated for helping joint customers modernize their data architectures with Starburst, delivering integrated, high-performance solutions that bring the power of governed, federated analytics to enterprises at scale, and enabling organizations to accelerate their AI and data-driven initiatives.
  • Integration & Ecosystem Impact Award Winner: Alteryx
    Alteryx is honored for delivering seamless integration and technical innovation that extend the value of Starburst, enabling organizations to achieve new levels of interoperability and business impact.
  • Managed Service Excellence Award Winner: Kubrick
    Kubrick is recognized for outstanding implementation expertise, customer satisfaction, and the ability to drive transformative outcomes through high-impact Starburst deployments.

“Data and AI are the engines of transformation across every industry,” said Steven Chung, President of Starburst. “The winners of this year’s Data Visionary Awards exemplify what’s possible when bold vision, strong leadership, and execution come together with the power of Starburst. We’re proud to celebrate these customers and partners who are setting the standard for the future of data and AI.”

Supporting Resources

About Starburst
Starburst is the data platform built for flexibility, delivering fast, secure access to all your data, wherever it lives. Whether on-premises, across clouds, or in hybrid environments, Starburst provides choice and control to your architecture. Built on an open data stack with Trino and Apache Iceberg, it unifies distributed data without complex or costly migrations, unleashing the full power of the data lakehouse for analytics and AI.

With our Lakeside AI architecture, enterprises gain federated access, governed collaboration, and full data lineage, laying the foundation for scalable, compliant AI innovation. Starburst empowers data-intensive and security-conscious organizations to unlock the full potential of their data while ensuring performance, governance, and control.

Enterprises in 60+ countries, including Comcast, Citigroup, and 4 of the top 5 global banks, trust Starburst to maximize data value. Our strategic partnerships with AWS, Dell Technologies, and top cloud providers ensures seamless interoperability across environments.
From insights to action to AI, Starburst fuels innovation at every level. Learn more at starburst.ai.

DXC Named a Leader in Property and Casualty Insurance in Everest Group Assessment of BPS Providers

Recognition highlights DXC’s market-leading technology, AI innovation, and industry expertise

ASHBURN, Va., Oct. 14, 2025 /PRNewswire/ — DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, has been named a Leader by global research firm Everest Group in its new report, “Property and Casualty (P&C) Insurance BPS PEAK Matrix® Assessment 2025.” DXC was also awarded Star Performer status for demonstrating forward and upward movement from the previous edition of the report published in 2023.

DXC Named a Leader in Property and Casualty Insurance in Everest Group Assessment of BPS Providers
DXC Named a Leader in Property and Casualty Insurance in Everest Group Assessment of BPS Providers

The Everest Group report highlights DXC’s strengths in utilizing AI to reduce time and cost of policy and data migrations, providing business process services (BPS) that are tightly aligned with DXC’s proprietary Assure Platform solutions, and enabling rapid development of capabilities with a dedicated insurance R&D function. DXC’s commitment to innovation has allowed the company to deploy value-add solutions such as AI accelerators and Assure BPM, powering the modernization of operations for insurance customers globally.

“DXC Technology’s platform-led model anchored by its Assure platform and proprietary insurance software with domain-specific IP simplifies AI deployment and enables continuous modernization of P&C operations at scale,” says Abhimanyu Awasthi, Practice Director at Everest Group. “Backed by domain-led solutions, deep London Market expertise, and broad geographic coverage, DXC powers mission-critical processes across personal, commercial, specialty, and reinsurance lines, turning complexity into operational gains.”

With over 40 years of industry expertise, DXC is a trusted partner of choice for 21 of the top 25 insurers. As a leading provider of core insurance systems, DXC continues to innovate—helping insurers reduce complexity and costs across more than 1 billion policies processed on DXC software.

“DXC’s drive to innovate, global presence, and industry expertise allows us to meet the needs of  our customers around the world – from accelerating expansion into new markets with our BPS offerings, to shaping the future of specialty insurance through our strategic Velonetic joint venture,” said Ray August, President of Insurance Software and Business Process Services at DXC. “Our mission is to empower insurers with innovative solutions, including AI and emerging technologies, to help them compete effectively and address key market trends with offerings tailored to global markets. We’re honored to have this work recognized by Everest Group.”

Everest Group evaluated 25 P&C insurance BPS providers for its P&C Insurance BPS PEAK Matrix® Assessment 2025, separating companies into three categories: Leaders, Market Contenders, and Aspirants. The report assessed providers’ vision, capabilities, and market impact.

An excerpt of Everest Group’s report is available to view here. To learn more about DXC’s P&C offerings, click here.

About DXC Technology
DXC Technology (NYSE: DXC) is a leading global provider of information technology services. We’re a trusted operating partner to many of the world’s most innovative organizations, building solutions that move industries and companies forward. Our engineering, consulting and technology experts help clients simplify, optimize and modernize their systems and processes, manage their most critical workloads, integrate AI-powered intelligence into their operations, and put security and trust at the forefront. Learn more on dxc.com.

Disclaimer
Licensed extracts taken from Everest Group’s PEAK Matrix® Reports, may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis.  All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking.  To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports.

About Everest Group
Everest Group is a leading global research firm helping business leaders make confident decisions. Everest Group’s PEAK Matrix® assessments provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions, look to the PEAK Matrix® to gauge and calibrate their offerings against others in the industry or market. Find further details and in-depth content at www.everestgrp.com.

Media Contact: Angelena Abate, Media Relations, +1.646.234.8060, angelena.abate@dxc.com 

 

IMG Expands iTravelInsured Choice with New Add-Ons and Specialized Plans

INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ — IMG (International Medical Group) has announced new optional coverage add-ons to its most popular travel insurance plan, iTravelInsured Choice, and the launch of two new products.

Travelers now have the option to expand their iTravelInsured Choice coverage in several key areas through a variety of add-ons at an additional cost:

  • Cancel For Any Reason (CFAR) & Interruption For Any Reason (IFAR) coverage
  • Increased medical coverage
  • Additional benefits and covered reasons specific to cruises
  • Enhanced benefits to accommodate adventurous activities and traveling with sporting equipment

“At IMG, we know travel isn’t one-size-fits-all, and neither is travel insurance,” said Justin Poehler, Chief Commercial Officer at IMG. “With these new add-on options, travelers can easily customize their iTravelInsured Choice plan and choose the coverage that’s best for their trip, whether they want extra medical protection or coverage tailored to adventure sports.”

Building on this flexibility, IMG has also introduced two new products under the iTravelInsured Choice umbrella. iTravelInsured Choice Cruise is a new plan designed specifically for cruise travelers, with additional benefits and covered reasons addressing excessive water levels, port closures, mechanical issues, and more. iTravelInsured Choice Departure is another new product designed for travelers with little to no non-refundable trip expenses, providing primary coverage for medical expenses and key emergency benefits and services.

“With the launch of iTravelInsured Choice Cruise and iTravelInsured Choice Departure, we’re giving travelers more targeted protection based on how and where they travel,” said Grant Hayes, Global Head of Travel at IMG. “Whether you’re setting sail or heading overseas, there is an iTravelInsured Choice plan to meet your trip’s specific needs and provide you with global peace of mind.”

To learn more about IMG’s award-winning travel and health safety solutions, please visit www.imglobal.com.

About IMG® (International Medical Group®)
IMG® (International Medical Group®), a SiriusPoint company, is an award-winning global insurance benefits and assistance services company that has served millions of members worldwide since its founding in 1990. The preeminent provider of travel and health safety solutions, IMG offers a wide range of insurance programs, including international private medical insurance, travel medical insurance, and travel insurance, as well as enterprise services, including insurance administrative services and 24/7 emergency medical, security, and travel assistance. IMG’s world-class services, combined with an extensive product portfolio, provide Global Peace of Mind® for travelers, students, missionaries, marine crews, and other individuals or groups traveling, working, or living away from home. For more information, please visit www.imglobal.com.

Media Contact: Carly Kessler, IMG Communications Manager, carly.kessler@imglobal.com

Securing Global Financial Transactions: ReconArt Achieves 70% Faster Compliance with Armor Defense and Oracle

DALLAS, Oct. 14, 2025 /PRNewswire/ — ReconArt, a leading provider of enterprise-class reconciliation and financial solutions, announced it has selected Armor Defense’s Managed Detection and Response (MDR) services on Oracle Cloud Infrastructure (OCI) to secure its high-performance financial platform.

In financial services, precision and resilience are non-negotiable. A single missed transaction or failed control can trigger financial loss, regulatory action, or lasting reputational damage. Sustaining this precision and resilience demands Armor’s advanced defense – anticipating and neutralizing threats before they disrupt business.

“ReconArt has trusted Armor for over 15 years. This new Armor + OCI solution supports our global customers such as Expedia, Daikin, BMO, and Klar, some processing more than 30 million transactions per day,” said Ivan Popov, CTO of ReconArt. “Armor’s proactive security and compliance expertise – combined with OCI’s performance – gives us the confidence to innovate. We know our platform is secure, compliant, and resilient at scale.”

The new solution provides ReconArt with measurable, strategic advantages:

  • 6X performance capacity, ensuring speed and accuracy at scale.
  • 70% faster time to compliance across regulations and frameworks, including PCI DSS, SOC 2, ISO 27001, GDPR, and DORA.
  • AI-accelerated threat detection and response, powered by Armor’s 24×7 security operations and agentic AI.

ReconArt’s customers – accounting and finance teams operating under relentless regulatory scrutiny – are seeing fewer disruptions, faster audits, and greater trust in their data.

“ReconArt exemplifies how financial organizations can turn compliance and security into a growth advantage,” said Chris Drake, Founder and CEO of Armor Defense. “By integrating Oracle Cloud Guard and Security Zones, we’re helping enterprises protect what matters most – without slowing innovation.”

Powered by Armor’s intelligent security operations and Oracle’s high-performance infrastructure, ReconArt ensures every transaction is trusted, every audit is simplified, and every growth opportunity is secure.

Armor will feature ReconArt and other enterprise success stories at Oracle AI World, October 13 – 16 in Las Vegas. 

About Armor

Armor is a global leader in cloud-native managed detection and response. Trusted by over 1,700 organizations across 40 countries, Armor delivers cybersecurity, compliance consulting, and 24/7 managed defense built for transparency, speed, and results. By combining human expertise with AI-driven precision, Armor safeguards critical environments to outpace evolving threats and build lasting resilience. For more information, visit our website, follow us on LinkedIn, or request a free Cyber Resilience Assessment.